MC10 Collaborates with AbbVie for Multiple Sclerosis Clinical Trials Using BioStamp nPoint system

MC10 AbbVie partnership

MC10, a Massachusetts-based startup specializing in wearable digital health sensors, and AbbVie, a global biopharmaceutical company, are working together on clinical trials in patients with multiple sclerosis (MS) using the BioStamp nPoint system.

Related Shimmer Launches Verisense™ Wearable Sensor Platform for Clinical Trials

The new partnership aims to explore the use of data from the nPoint® System in order to provide unique insights into MS clinical studies.

“We are excited to work with a world leader in CNS therapies and look forward to exploring novel data and metrics that help to advance clinical development,” said Dr Arthur Combs, Chief Medical Officer of MC10.

BioStamp nPoint System, which received 510(k) from the FDA, was developed for use in clinical trials and other applications for the continuous collection of physiological data. The system is optimized for both in-home and in-clinic use. The BioStamp nPoint System reports vital signs, activity and postural classifications and a suite of sleep metrics. Today, numerous pharmaceutical companies and academic research across several therapeutic areas use this system, said MC10 in a press release.

Dr. Michael Gold, Vice President, Development Neurosciences, of AbbVie said:

“We are excited to explore the BioStamp nPoint System’s ability to unobtrusively collect clinically relevant data continuously from subjects in more natural settings. This technology has the potential to improve the quality of data we collect and at the same time reduce the burden on study participants.”

Office building of AbbVie

Related Oracle mHealth Platform is Revolutionizing Clinical Trials with Remote Monitoring Devices

Based in Lexington, Massachusetts, MC10 combines its proprietary ultra-thin, flexible body-worn sensors with advanced analytics to unlock health insights from physiological data.

Lake Bluff, Illinois-based AbbVie was founded in 2013 as a spin-off of Abbott Laboratories.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19